valine and phenothiazine

valine has been researched along with phenothiazine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blower, PE; Durinck, S; Futreal, AP; Ikediobi, ON; Reimers, M; Stratton, MR; Weinstein, JN	1
Belei, D; Bîcu, E; Dubois, J; Dumitriu, GM; Farce, A; Ghinet, A; Rigo, B	1

Other Studies

2 other study(ies) available for valine and phenothiazine

Article	Year
In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation. Molecular cancer therapeutics, 2008, Volume: 7, Issue:6 Topics: Amino Acid Substitution; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Codon; Drug Screening Assays, Antitumor; Glutamic Acid; Humans; Melanoma; Mutant Proteins; Mutation; Phenothiazines; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; ras Proteins; Reproducibility of Results; Valine	2008
Phenothiazine-based CaaX competitive inhibitors of human farnesyltransferase bearing a cysteine, methionine, serine or valine moiety as a new family of antitumoral compounds. Bioorganic & medicinal chemistry letters, 2015, Oct-15, Volume: 25, Issue:20 Topics: Amino Acids; Antineoplastic Agents; Cysteine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Methionine; Molecular Structure; Phenothiazines; Serine; Structure-Activity Relationship; Valine	2015

Article

Year

In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation.

Molecular cancer therapeutics, 2008, Volume: 7, Issue:6

Topics: Amino Acid Substitution; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Codon; Drug Screening Assays, Antitumor; Glutamic Acid; Humans; Melanoma; Mutant Proteins; Mutation; Phenothiazines; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; ras Proteins; Reproducibility of Results; Valine

2008

Phenothiazine-based CaaX competitive inhibitors of human farnesyltransferase bearing a cysteine, methionine, serine or valine moiety as a new family of antitumoral compounds.

Bioorganic & medicinal chemistry letters, 2015, Oct-15, Volume: 25, Issue:20

Topics: Amino Acids; Antineoplastic Agents; Cysteine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Methionine; Molecular Structure; Phenothiazines; Serine; Structure-Activity Relationship; Valine

2015